Target intelligence / Profile preview

MicroRNA-598 (miR-598)

Target
miR-598
Molecular classification
microRNA, Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA-598 is a member of the small non-coding RNA family that regulates gene expression post-transcriptionally. It is typically downregulated in several cancers, including non-small cell lung cancer, triple-negative breast cancer, ovarian cancer, colorectal cancer, and gastric cancer. Restoration or mimicry of miR-598 inhibits tumor cell proliferation, migration, invasion, and promotes apoptosis, primarily by silencing oncogenic targets such as ZEB2, JAG1, URI, and IGF1R. Its tumor suppressor role makes it a promising prognostic biomarker and candidate for RNA-based cancer therapies, though no approved drugs currently target miR-598 directly. Its main molecular classification is as a microRNA, and it is not a receptor, enzyme, transporter, or transcription factor.

Other names
MIR598hsa-mir-598mir-598MIRN598miR-598-3p
02

Mechanism of action

miR-598 acts by binding to the 3′ untranslated regions (3′-UTRs) of target mRNAs, leading to their degradation or translational inhibition. It directly suppresses oncogenic proteins, e.g., ZEB2 (NSCLC), JAG1 (breast cancer), URI (ovarian cancer), IGF1R (gastric cancer). It also indirectly modulates signaling pathways such as ERK/Akt and cell cycle regulators.

03

Biological functions

Regulation of cell proliferationInhibition of cell migration and invasionInduction of cell cycle arrestPromotion of apoptosisRegulation of gene expression through mRNA silencing
04

Disease associations

Cancer (Non-small cell lung cancer, triple-negative breast cancer, gastric cancer, ovarian cancer, colorectal cancer, osteosarcoma)Tumor suppressionNeuropsychiatric disorders (less characterized, but suggested)
05

Safety considerations

The primary therapeutic challenge is efficient and specific delivery of miR-598 or its mimics into tumors; off-target effects and immune reactions are possible concerns with RNA-based therapeutics
06

Biomarkers

Low expression of miR-598 is a potential prognostic biomarker for metastasis and poor outcome in various cancers (NSCLC, TNBC, ovarian cancer, gastric cancer)

Beyond the preview

Go deeper on MicroRNA-598 (miR-598).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-598 (miR-598).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call